Talk:Frank L. Douglas

This article must adhere to the biographies of living persons (BLP) policy, even if it is not a biography, because it contains material about living persons. Contentious material about living persons that is unsourced or poorly sourced must be removed immediately from the article and its talk page, especially if potentially libellous. If such material is repeatedly inserted, or if you have other concerns, please report the issue to this noticeboard.

If you are a subject of this article, or acting on behalf of one, and you need help, please see this help page.

Biography: Science and Academia

	Biography portal This article is within the scope of WikiProject Biography, a collaborative effort to create, develop and organize Wikipedia's articles about people. All interested editors are invited to join the project and contribute to the discussion. For instructions on how to use this banner, please refer to the documentation.BiographyWikipedia:WikiProject BiographyTemplate:WikiProject Biographybiography
	This article is supported by the science and academia work group.

Medicine Low‑importance

	Medicine portal This article is within the scope of WikiProject Medicine, which recommends that medicine-related articles follow the Manual of Style for medicine-related articles and that biomedical information in any article use high-quality medical sources. Please visit the project page for details or ask questions at Wikipedia talk:WikiProject Medicine.MedicineWikipedia:WikiProject MedicineTemplate:WikiProject Medicinemedicine
Low	This article has been rated as Low-importance on the project's importance scale.

African diaspora

	This article is within the scope of WikiProject African diaspora, a collaborative effort to improve the coverage of African diaspora on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.African diasporaWikipedia:WikiProject African diasporaTemplate:WikiProject African diasporaAfrican diaspora
???	This article has not yet received a rating on the project's importance scale.

The following references may be useful when improving this article in the future:

Wall Street Journal coverage of Douglas's mid-career

External links modified

Hello fellow Wikipedians,

I have just added archive links to one external link on Frank L. Douglas. Please take a moment to review my edit. If necessary, add {{cbignore}} after the link to keep me from modifying it. Alternatively, you can add {{nobots|deny=InternetArchiveBot}} to keep me off the page altogether. I made the following changes:

Added archive https://web.archive.org/20070326074227/http://web.mit.edu:80/cbi/people/Douglas_bio.html to http://web.mit.edu/cbi/people/Douglas_bio.html

When you have finished reviewing my changes, please set the checked parameter below to true to let others know.

This message was posted before February 2018. After February 2018, "External links modified" talk page sections are no longer generated or monitored by InternetArchiveBot. No special action is required regarding these talk page notices, other than regular verification using the archive tool instructions below. Editors have permission to delete these "External links modified" talk page sections if they want to de-clutter talk pages, but see the RfC before doing mass systematic removals. This message is updated dynamically through the template {{source check}} (last update: 5 June 2024).

If you have discovered URLs which were erroneously considered dead by the bot, you can report them with this tool.
If you found an error with any archives or the URLs themselves, you can fix them with this tool.

Cheers.—^{cyberbot II}_{Talk to my owner:Online} 20:35, 24 January 2016 (UTC)[reply]

Notability

I think that Douglas is weakly notable under WP:NPROF C1, for several highly cited papers. Additionally, his resignation from MIT some years ago got a fair bit of coverage at the time [1] [2] [3] [4]. The interview in Nature Reviews Drug Discovery helps support. This would be pretty weak for GNG, but together with the NPROF case, I think there's a solid case for keeping the article. Pinging PRODer @Ohnoitsjamie: I'll try to do some reworking of the article over the next few days. Russ Woodroofe (talk) 17:33, 6 January 2021 (UTC)[reply]

While I frequently take my disputed prods to AfD, I think the additional sources you found probably gives the subject just enough coverage to squeak by. While looking for the original GQ source, came across this, which is an OK source with good coverage. Cheers, OhNoitsJamie ^Talk 17:52, 6 January 2021 (UTC)[reply]

Comments on the recent edits; overall, the article looks much better, especially the refactored/pruned awards section (lengthy and exhaustive "awards" sections are one of the most obvious COI flags). Glancing at the references section, it's still a bit weighted toward primary sources (CVs, institutional bio pages); two of the third-party reliable sources are about the same event (MIT resignation). The Akron Life source mentioned above could help, though it could also be argued that it's "local coverage" (a profile in a community newspaper usually isn't enough by itself for WP:BIO). If it went to AfD now it could go either way. Personally I think it's borderline enough that I wouldn't send it to AfD. If someone else did, I'd likely !vote "weak keep" at this point. OhNoitsJamie ^Talk 14:56, 8 January 2021 (UTC)[reply]

Ohnoitsjamie, thanks for commenting! I have a fair bit of confidence that any AfD discussion would end in a keep. I'm mainly looking to improve the article. I did shore up the sourcing a little more: I think that it's mainly weak on the middle of his career now (say, Xerox through Aventis). There appears quite a bit more available on the WSJ about his role at Aventis, if someone with a subscription comes by here. Russ Woodroofe (talk) 15:30, 20 January 2021 (UTC)[reply]